CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:CAR T-cell behavior and function revealed by real-time imaging.
CAR T-cell behavior and function revealed by real-time imaging.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
表达嵌合抗原受体(CAR)的T细胞过继转移已在晚期B细胞恶性肿瘤治疗中显示显著临床疗效。然而,CAR-T 细胞领域目前仍面临若干重大挑战。尤其是靶向实体瘤时,CAR-T 细胞策略尚未取得理想临床反应。
因此,了解限制T细胞免疫疗法疗效的决定因素至关重要。CAR-T 细胞通常通过流式细胞术和全转录组分析进行表征;这些方法对于确定影响T细胞增殖和扩增能力的内在因素非常有价值,但未考虑T细胞反应的空间和动力学特征。特别是,为控制肿瘤生长,CAR-T 细胞必须进入肿瘤,在复杂肿瘤环境中迁移,并与靶细胞形成有效接触。先进成像技术与创新性临床前模型相结合,为揭示CAR-T 细胞动态提供了有前景的工具。本综述讨论近期利用实时成像显微技术获得的工程化T细胞生物学研究结果。基于成像的研究提出了重要认识,例如CAR-T 细胞具有多重杀伤潜力。
最后,本文介绍如何将成像技术与其他工具结合,以解决工程化T细胞领域尚未解答的问题。
Adoptive transfer of T-cells expressing chimeric antigen receptors (CAR) has shown remarkable clinical efficacy against advanced B-cell malignancies. Nonetheless, the field of CAR T-cells is currently facing several major challenges. In particular, the CAR T-cell strategy has not yet produced favorable clinical responses when targeting solid tumors.
In this context, it is of paramount importance to understand the determinants that limit the efficacy of T-cell-based immunotherapy. Characterization of CAR T-cells is usually based on flow cytometry and whole-transcriptome profiling. These approaches have been very valuable to determine intrinsic elements that condition T-cell ability to proliferate and expand.
However, they do not take into account spatial and kinetic aspects of T-cell responses. In particular, in order to control tumor growth, CAR T-cells need to enter into the tumor, migrate within a complex tumor environment, and form productive conjugates with their targets.
Advanced imaging techniques combined with innovative preclinical models represent promising tools to uncover the dynamics of CAR T-cells. In this review, we will discuss recent results on the biology of engineered T-cells that have been obtained with real-time imaging microscopy. Important notions have emerged from these imaging-based studies, such as the multi-killing potential of CAR T-cells.
Finally, we will highlight how imaging techniques combined with other tools can solve remaining unresolved questions in the field of engineered T-cells.
MEMBER ACCOUNT
登录成功会直接打开下一页。